AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimisave M3 750 Tablet PR

Prescription Icon
Prescription Required

Marketer

Eris Lifesciences Ltd

Salt Composition

Glimepiride (3mg) + Metformin (750mg)

Overview Glimisave M3 750 Tablet PR

Diabetacomb 750mg tablets are antidiabetic medications combining two active ingredients to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose. Always take Diabetacomb 750mg with food, consistently at the same time daily for optimal effectiveness. Your physician will determine your appropriate dosage, potentially adjusting it based on your blood sugar response. Continue taking this medication as prescribed, even if feeling well or achieving good glucose control. Abrupt cessation without consulting your doctor risks elevated blood sugar, increasing the likelihood of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan including a balanced diet, regular physical activity, and weight management as advised by your healthcare provider. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and trembling, and know how to treat it promptly. Maintain regular mealtimes and carry a rapid-acting glucose source like sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Do not use Diabetacomb 750mg if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver impairment. Inform your doctor of any prior heart conditions before starting treatment, as this medication may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor before use. Regular blood glucose monitoring is essential, and your doctor might recommend blood tests to check blood cell counts and liver function.

Primary Ingredients of Glimisave M3 750 Tablet PR

No text provided. Please provide the text you would like me to rephrase.

Uses of Glimisave M3 750 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimisave M3 750 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Administer Glimisave M3 750 Tablet PR with food.

Common Side effects of Glimisave M3 750 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimisave M3 750 Tablet PR:

Always follow your physician's instructions or consult the product label for proper administration. Ingest Glimisave M3 750 Tablet PR with a meal.

How Glimisave M3 750 Tablet PR works:

Glimisave M3 750 PR tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimisave M3 750 Tablet PR with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimisave M3 750 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not use Glimisave M3 750 Tablet PR. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimisave M3 750 Tablet PR, potentially requiring dosage modification under medical supervision. Glimisave M3 750 Tablet PR is contraindicated in those with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimisave M3 750 Tablet PR to individuals with hepatic impairment. Dosage modification of Glimisave M3 750 Tablet PR may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate Glimisave M3 750 Tablet PR therapy at a reduced dosage; its use is contraindicated in those with severe liver disease.

What if you forget to take Glimisave M3 750 Tablet PR :

Should you forget a Glimisave M3 750 Tablet PR dose, take it immediately if you remember. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Never take a double dose.

Facts to Know About Glimisave M3 750 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimisave M3 750 Tablet PR

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication. Keep it out of reach of children, pets, and others.
Glimisave M3 750 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimisave M3 750 Tablet PR and seek immediate medical attention.
Glimisave M3 750 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glimisave M3 750 Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimisave M3 750 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Glimisave M3 750 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimisave M3 750 Tablet PR with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimisave M3 750 Tablet P...
181
MRP 209
13% off